A new meta-analysis combining 22 studies, to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 October), shows that tirzepatide is superior to semaglutide for both control of blood sugar and in terms of amount of body weight lost by patients. The study is by Dr. Thomas Karagiannis, Aristotle University of Thessaloniki, Thessaloniki, Greece, and colleagues.
from Medical Xpress - latest medical and health news stories https://ift.tt/mzIrjqT
